| Today, Tue, Nov 10, 2009 | | • | Xenomics files patent for new technology to test HPV
at Reuters (Tue 5:13pm)
| | • | Small size, national plans help Europe's H1N1 fight
at Reuters (Tue 11:13am)
| | • | Bristol-Myers buys rights to RA drug $85 million
at Reuters (Tue 7:00am)
| | • | UPDATE - GSK to donate 50 mln doses of H1N1 vaccine to WHO
at Reuters (Tue 6:12am)
| | Mon, Nov 9, 2009 | | • | UPDATE - Venezuela slows Amazon Indian swine flu outbreak
at Reuters (Mon 3:42pm)
| | Sun, Nov 8, 2009 | | • | Cramer's Mad Money - Distressed Tessera (11/4/09)
at Seeking Alpha (Sun, Nov 8)
| | Sat, Nov 7, 2009 | | • | UPDATE - Glaxo Saudi's sole supplier of H1N1 vaccine for now
at Reuters (Sat, Nov 7)
| | Fri, Nov 6, 2009 | | • | No Product Revenues, Plenty of Risk: Buy Exelixis?
at CNBC (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Don't Bet on a Return to a 'Normal' IPO Market
at BusinessWeek (Thu, Nov 5)
| | • | H1N1 shows no widespread antiviral resistance - WHO
at Reuters (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | The Return of Immunogen?
at CNBC (Wed, Nov 4)
| | • | Safe signals from Buffett's train deal
at FT.com (Wed, Nov 4)
| | Thu, Oct 29, 2009 | | • | UPDATE - Ipsen ups margin goal, diabetes drug hits test target
at Reuters (Thu, Oct 29)
| | • | UPDATE - Roche, Ipsen diabetes drug meets late-stage target
at Reuters (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | UPDATE - Swine flu gives Glaxo a shot in the arm
at Reuters (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | Los Angeles OKs plan to use Google Web services
AP (Tue, Oct 27)
| | • | UPDATE - Glaxo, Genmab win U.S. approval for leukaemia drug
at Reuters (Tue, Oct 27)
| | Thu, Oct 22, 2009 | | • | Seattle Genetics 3Q loss narrows on partnerships
AP (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | • | Genentech's Levinson joins biotech startup's board
at Reuters (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | UPDATE - Gilead profit up 36 pct, HIV sales disappoint
at Reuters (Tue, Oct 20)
|
Add DNA News to My Yahoo!:
 
| |
|
0.20% Nasdaq 
0.14%
Headlines
